|
GRPEL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.07256434237024E-12 |
| Normal-vs-Stage2 |
1.69828999999622E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
9.48363609865055E-12 |
| Stage1-vs-Stage2 |
9.841400E-01 |
| Stage1-vs-Stage3 |
5.031400E-04 |
| Stage1-vs-Stage4 |
4.285700E-02 |
| Stage2-vs-Stage3 |
4.385700E-02 |
| Stage2-vs-Stage4 |
1.940170E-01 |
| Stage3-vs-Stage4 |
4.362800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.29019994687951E-09 |
| Normal-vs-Asian |
5.71069999999452E-05 |
| Caucasian-vs-AfricanAmerican |
5.905200E-01 |
| Caucasian-vs-Asian |
5.034400E-01 |
| AfricanAmerican-vs-Asian |
6.495800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
3.36319971872001E-10 |
| Male-vs-Female |
9.577300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.59949999975784E-07 |
| Normal-vs-Age(41-60Yrs) |
1.88737914186277E-15 |
| Normal-vs-Age(61-80Yrs) |
5.10702591327572E-15 |
| Normal-vs-Age(81-100Yrs) |
4.620800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.403900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.833800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.042300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.421600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.438600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.030000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.821500E-04 |
| Normal-vs-Grade 2 |
3.41837669282086E-13 |
| Normal-vs-Grade 3 |
4.44089209850063E-16 |
| Normal-vs-Grade 4 |
3.94240196044393E-13 |
| Grade 1-vs-Grade 2 |
9.856400E-01 |
| Grade 1-vs-Grade 3 |
5.509200E-01 |
| Grade 1-vs-Grade 4 |
2.882800E-01 |
| Grade 2-vs-Grade 3 |
6.176000E-02 |
| Grade 2-vs-Grade 4 |
1.039530E-02 |
| Grade 3-vs-Grade 4 |
3.109400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.37740000411202E-08 |
| Normal-vs-ccB subtype |
1.11022302462516E-16 |
| ccA subtype-vs-ccB subtype |
3.06879999190102E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62470037423645E-12 |
| Normal-vs-N1 |
1.362900E-03 |
| N0-vs-N1 |
8.861800E-01 |
|
|
